Skip to Main Content

Paper Details

Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern.
Blood Adv
40
2022
CCP, CCP antibody, COVID-, COVID-19, Euroimmun S1 immunoglobulin G antibody, SARS, SARS-CoV, SARS-CoV-2, hyperimmunoglobulin, immunosuppressed, postvaccination units, pre-?, severe acute respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 2
Author NameAffiliation
Oliver LaeyendeckerNational Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)
Aaron A R TobianJohns Hopkins University School of Medicine
Michael J JoynerMayo Clinic
Evan M BlochJohns Hopkins University School of Medicine
Shmuel ShohamJohns Hopkins University School of Medicine
Sonya L HeathUniversity of Alabama at Birmingham
Kelly A GeboNational Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health
Andrew PekoszJohns Hopkins Bloomberg School of Public Health
  • 1 - 10

Datasets

Release 1.2